BACULOVIRUS EXPRESSION SYSTEM MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Baculovirus Expression System Market, By Product Type (Baculovirus, Expression Vector, Reagents, and Others), By Application (Therapeutics, Vaccines, Protein Purification, and Others), By End User (Biopharmaceutical Companies, Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Baculovirus Expression System Market Regional Insights:

North America is expected to be the largest market for baculovirus expression systems during the forecast period, which accounted for over 33.5% of the market share in 2022. The growth of the market in North America is attributed to the strong presence of leading biopharmaceutical companies, significant R&D investments, and rapid adoption of advanced technologies.
Europe is expected to be the second-largest market for baculovirus expression systems, which accounted for over 25.1% of the market share in 2022. This is due to the increasing demand for recombinant proteins from the pharmaceutical and biotechnology industries in the region.
Asia Pacific is expected to be the fastest-growing market for baculovirus expression systems, with a CAGR of over 19.2% during the forecast period. The growth of the market in Asia Pacific is attributed to the increasing demand for protein therapeutics, rising investments in R&D infrastructure, and growing outsourcing of bio production by global biopharmaceuticals

Figure 1. Global Baculovirus Expression System Market Share (%), by Region, 2023

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East